Image

Clinical Safety Guidelines for Managing Distal Shoe Complications

Clinical Safety Guidelines for Managing Distal Shoe Complications

Recruiting
3-9 years
All
Phase N/A

Powered by AI

Overview

Distal shoe space maintainers are the standard of care for guiding the eruption of permanent first molars following the premature loss of the primary second molars. Although this therapy represents established clinical practice, prospective evidence regarding soft tissue complications and predictors of treatment outcomes remains limited. This observational study will prospectively collect clinical outcome data during routine treatment visits. The aims of the study are to characterize patterns of complications, evaluate outcomes related to patient adherence, and identify predictors of treatment success. Ultimately, this study seeks to support the development of standardized strategies for clinical monitoring and complication management.

Description

The premature loss of a primary second molar prior to the eruption of the permanent first molar represents a significant clinical challenge in pediatric dentistry. Without appropriate intervention, the unerupted permanent first molar invariably drifts mesially during its eruptive path, resulting in severe arch length deficiency, impaction of the permanent second premolar, and complex malocclusions. The distal shoe space maintainer is the definitive intervention for these cases; its subgingival guide plane acts as a critical buttress, directing the permanent first molar into its correct anatomical position.

Despite its status as a standard clinical procedure, standardized clinical monitoring protocols and evidence-based complication management strategies remain limited. Current literature is primarily restricted to case reports and small retrospective series characterized by substantial heterogeneity in appliance design, follow-up intervals, and criteria for clinical success. Consequently, existing data offer descriptive or anecdotal observations rather than robust, prospective evidence. This gap in the literature leaves several critical clinical concerns unresolved:

Histological and Soft Tissue Ambiguity: Because the appliance's distal extension penetrates the gingival epithelium, it creates a potential pathway for bacterial ingress. There is a significant dearth of prospective data regarding long-term gingival health, the nature of the epithelial attachment, and the chronic inflammatory response at the subgingival metal interface.

Non-Standardized Complication Management: Clinicians currently lack a universal framework or validated assessment tool for managing prevalent complications, such as localized gingival inflammation, ulceration, appliance fracture, or cement failure.

Uncertain Predictors of Success: In the absence of systematic longitudinal monitoring, it remains difficult to quantify how patient-specific variables-specifically oral hygiene adherence and individual gingival reactivity-influence overall treatment success and post-operative morbidity.

Therefore, this prospective study is essential to systematically investigate soft tissue responses and complication patterns. By documenting these outcomes through standardized follow-up and data collection protocols, this research aims to establish evidence-based clinical guidelines and a decision-making framework to optimize treatment outcomes and minimize patient morbidity.

Eligibility

Inclusion Criteria

  • Pediatric participants aged 3 to 9 years
  • American Society of Anesthesiologists (ASA) Physical Status I or II
  • Clinical indication for distal shoe therapy as the standard of care
  • Undergoing distal shoe space maintainer placement
  • Parent or caregiver able to provide consent and comply with follow-up visits

Exclusion Criteria

  • Presence of systemic medical conditions that may affect bone metabolism or wound healing
  • Patients unable or unwilling to comply with the planned follow-up schedule (up to 24 months)
  • Patients with contraindications to distal shoe therapy based on clinical judgment

Study details
    Premature Loss of Primary Molars
    Space Maintainer
    Soft Tissue Inflammation

NCT07410442

University of Florida

13 May 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.